1.创新药物研究。在国家十一五期间,令我国药学界科研工作者为之振奋的是国家投入了6亿人民币在重大新药创制的科研方面,这样给我们提供了机遇和挑战。在原创新药(化合物)开发的过程中,需经过化合物的合成与筛选,临床前的动物研究,临床人体试验Ⅰ～Ⅲ期,以及上市后的Ⅳ期临床研 1. Innovative drug research. During the period of the 11th Five-Year Plan, researchers in our pharmaceutical field are greatly encouraged by the fact that the state has invested 600 million yuan in scientific research on the creation of major new drugs, thus giving us opportunities and challenges. In the process of developing original new drugs (compounds), we need to go through compound synthesis and screening, preclinical animal studies, clinical human trials Ⅰ ~ Ⅲ, and post-marketing phase Ⅳ clinical research